2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Dean Fennell
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Dean Fennell
Login to view comments.
Click here to Login